glp 1 cost plus drugs GLP-1 Antagonists Increase Plan Drug Spend - What's Next Cost comparison for GLP-1 agonist

doi: 10.2337/dc17-0589 44 XieJEl SayedNMQiCZhaoXMooreCEHerbertTP

February 6, 2026: Newer, Potentially Stronger Weight Loss Injections May Outperform Zepbound At least two new GLP-1 drugs may enter the market soon, and their manufacturers claim they can help patients lose up to twice as much weight compared to Zepbound and other weight loss drugs

Data related to demographic information, such as authors, year of study, country, study population, study design, and primary outcomes, such as colorectal cancer risk, were extracted (Table 1)

& Shannon, R

Another study a meta-analysis and review of 78 trials involving more than 73,000 participants concluded that semaglutide was associated with an increased incidence of NAION but emphasized that evidence for a causal link remains inconclusive

Conclusions This study explored the relationship between GLP-1RAs and SSIBs through disproportionality analysis